Dr. Jennifer Hsiao provides key takeaways from her presentation on hidradenitis suppurativa, focusing on unroofing procedures and treatment strategies.
Topics Covered:
Explore Related Resources:
Hidradenitis Suppurativa: Causes, Features, and Current Treatments
Surgical Management of Hidradenitis Suppurativa: A Narrative Review
Dr. Marghoob discusses how the microanatomy of the face, palms, and nails impacts diagnosing melanomas.
Dr. Song provides an extensive overview of what’s new and emerging in atopic dermatitis treatment. Listen to Dr. Song’s full recap on our JCAD Podcast
Dr. Jenny Murase reviews a decade of insights on safety considerations for dermatologic treatments for pregnant and lactating patients. Topics Covered: Safe dermatologic treatments during
Dr. Murase reviews a decade of insights on safety considerations for dermatologic treatments for pregnant and lactating patients.
Dr. Hawkes discusses the closing gap between biologics and oral treatments for psoriasis and provides an update on a new oral IL-23 receptor inhibitor currently
Dr. Swanson discusses emerging treatments for atopic dermatitis, psoriasis, and alopecia areata in pediatric patients.
Dr. Hsiao discusses alternate long-term therapeutic options for patients with CSU.
Dr. High discusses two immunostains, p16 and PRAME, as well as gene expression profiling, as helpful tools for identifying melanoma.
Dr. High shares tips and insights regarding specialized considerations for biopsying a wide range of skin lesions.
Dr. Whitney High breaks down the biopsy and diagnosis process for rare nonmelanoma skin cancers like atypical fibroxanthoma and pleomorphic dermal sarcoma. Topics Covered: Nonmelanoma
Dr. Chilukuri discusses managing hyperpigmentation with pulse wave radiofrequency, chemical peels, and lasers.
Dr. Chilukuri discusses treating both medical and aesthetic dermatological concerns, including acne, hyperpigmentation, and scars, with cosmetic treatments.
Dr. Hawkes discusses the dermatological treatment of patients with cancer, whose immune system activating cancer treatments lead to cutaneous immunotoxicities, such as pruritus, psoriasis, and
